Glp-1 expression, suggested to be involved in the cognitive improvements seen in metformin-treated Type-2-Diabetes (T2D) patients 91, has been shown to be induced by taurinated deoxycholic acid (TDCA) in mice 92. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.